David Battat - Aug 21, 2024 Form 4 Insider Report for ATRION CORP (ATRI)

Role: President & CEO
Signature: /s/David Battat
Stock symbol: ATRI
Transactions as of: Aug 21, 2024
Transactions value $: -$44,241,093
Form type: 4
Date filed: 8/21/2024, 03:21 PM
Previous filing: Jul 11, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATRI	common stock	Disposed to Issuer	-$25.5M	-55.5K	-100%	$460.00	0	Aug 21, 2024	By Family Trust	F1
transaction	ATRI	common stock	Award	$0	+1.28K	+3.24%	$0.00	40.7K	Aug 21, 2024	Direct	F2
transaction	ATRI	common stock	Disposed to Issuer	-$18.7M	-40.7K	-100%	$460.00	0	Aug 21, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATRI	restricted stock units	Disposed to Issuer	$0	-1.16K	-100%	$0.00	0	Aug 21, 2024	common stock	1.16K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash.
F2	This amount represents performance stock units previously granted to the Reporting Person that vested in connection with the Merger.

Content

Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger, dated as of May 28, 2024, by and among Nordson Corporation, Alpha Medical Merger Sub, Inc., a wholly owned subsidiary of Nordson, and Atrion Corporation. At the effective time of the Merger, (i) each issued and outstanding share of common stock and (ii) each restricted stock unit, performance-based stock unit and deferred stock unit, were thereupon canceled and converted into the right to receive $460.00 in cash.

This amount represents performance stock units previously granted to the Reporting Person that vested in connection with the Merger.